These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 723760

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
    Rouffy J, Dreux C, Goussault Y, Dakkak R, Renson FJ.
    Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of hyperlipoproteinaemia in diabetic patients (author's transl)].
    Bruneder H, Klein HJ.
    Dtsch Med Wochenschr; 1981 Dec 04; 106(49):1653-6. PubMed ID: 7308007
    [Abstract] [Full Text] [Related]

  • 29. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ, Metz G, Specker M.
    Arzneimittelforschung; 1980 Dec 04; 30(11b):2053-8. PubMed ID: 7194059
    [Abstract] [Full Text] [Related]

  • 30. Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
    Schwandt P, Weisweiler P.
    Artery; 1980 Dec 04; 7(6):464-70. PubMed ID: 7236016
    [Abstract] [Full Text] [Related]

  • 31. [Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate].
    Mertz DP.
    Fortschr Med; 1980 Dec 04; 98(45):1761-6. PubMed ID: 7461569
    [Abstract] [Full Text] [Related]

  • 32. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J, Salonen J, Kuuisto P, Virtamo J, Manninen V, Mälkönen M.
    Proc R Soc Med; 1976 Dec 04; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [Abstract] [Full Text] [Related]

  • 33. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A, Buzzelli G, D'Alessandro A.
    Clin Ter; 1979 Apr 30; 89(2):127-49. PubMed ID: 226307
    [No Abstract] [Full Text] [Related]

  • 34. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H, Weidmann P, Fragiacomo C, Noseda G, Bachmann C.
    Schweiz Med Wochenschr; 1985 Jun 29; 115(26):907-11. PubMed ID: 3927481
    [Abstract] [Full Text] [Related]

  • 35. [Improvement in diabetes control by treatment with bezafibrate].
    Rüth E, Vollmar J.
    Dtsch Med Wochenschr; 1982 Oct 01; 107(39):1470-3. PubMed ID: 6749468
    [Abstract] [Full Text] [Related]

  • 36. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
    Kehely A, MacMahon M, Barbir M, Wray R, Hunt BJ, Prescott RJ, Thompson GR.
    QJM; 1995 Jun 01; 88(6):421-7. PubMed ID: 7648234
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate.
    Becker M, Staab D, Von Bergman K.
    Pediatrics; 1992 Jan 01; 89(1):138-42. PubMed ID: 1727999
    [Abstract] [Full Text] [Related]

  • 40. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
    Gavish D, Oschry Y, Fainaru M, Eisenberg S.
    Eur J Clin Invest; 1986 Feb 01; 16(1):61-8. PubMed ID: 3084275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.